Showing results (51-60 of 1,069) with videos related to

Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|November 6, 2014
High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case reportCarsten Saft, Ines Siglienti, Ralf Gold, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosisRebecca S Farber, Ilana K Sand
Therapeutic Advances in Neurological Disorders|May 2, 2019
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosisVinzenz Fleischer, Nabin Koirala, Amgad Droby, et al.
Therapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.
Therapeutic Advances in Neurological Disorders|October 21, 2021
Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhageWendy Bautista, P David Adelson, Nathan Bicher, et al.
Therapeutic Advances in Neurological Disorders|July 11, 2022
Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factorsSapir Dreyer-Alster, Shay Menascu, Roy Aloni, et al.
Therapeutic Advances in Neurological Disorders|April 28, 2022
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational studyTobias Moser, Ciara O'Sullivan, Ferdinand Otto, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Embolic strokes of undetermined source: theoretical construct or useful clinical tool?Georgios Tsivgoulis, Aristeidis H Katsanos, Martin Köhrmann, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging studyYu-Jie Yang, Jing-Jie Ge, Feng-Tao Liu, et al.
Therapeutic Advances in Neurological Disorders|June 4, 2019
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot studyMarilena Gubbiotti, Antonella Conte, Savino M Di Stasi, et al.
Pageof 107